Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart

Cell Biochemistry and Function

Volumn 26, Issue 2, 2008, Pages 238-245

  Briede, Janina ^a   Stivrina, Mara ^a   Vigante, Brigita ^a   Stoldere, Dzintra ^a   Duburs, Gunars ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

ATP; Cardiac physiological parameters; Cerebrocrast; Glucose uptake; LDH

Indexed keywords

1,4 DIHYDROPYRIDINE; ADENOSINE TRIPHOSPHATE; ANTIDIABETIC AGENT; CALCIUM; CALCIUM CHANNEL L TYPE; CEREBROCRAST; FATTY ACID; GLUCOSE TRANSPORTER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART RATE; ISOLATED HEART; MUSCLE CELL; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; GLUCOSE; HEART; HYPOGLYCEMIC AGENTS; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL CONTRACTION; ORGAN CULTURE TECHNIQUES; PERFUSION; RATS; RATS, WISTAR; TIME FACTORS;

RATTUS;

EID: 40649126576     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1442     Document Type: Article

References (49)

1. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. PNSA 1989; 86: 15141-15145.
2. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993; 87(Suppl. V): V-67-V-76.
3. Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 1998; 76: 21-31.
4. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001; 22: 36-52.
5. Devaray S, Venugopal SK, Singh U, Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-(alpha) and -(beta). Diabetes 2005; 54: 85-91.
6. Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996; 28: 964-971.
7. Yokoyama T, Nakamo M, Bednarezyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor -α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997; 95: 1247-1252.
8. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72: 561-566.
9. Rodrigues B. Cardiac dysfunction in isolated perfused hearts from spontaneously diabetic BB rats. Can J Physiol Pharmacol 1990; 68: 514-518.
10. Rodrigues B, Grassby PF, Battell ML, Lee SY, McNeill JH. Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunction. Can J Physiol Pharmacol 1994; 72: 447-455.
11. Cosentino F, Eto M, De Paolis P, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells. Role of protein kinase C and reactive oxygen species. Circulation 2003; 107: 1017-1023.
12. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; E14-E22.
13. Cheng XS, Shimokawa H, Momii H, et al. Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. Cardiovasc Res 1999; 42: 576-5577.
14. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 1994; 16: 383-391.
15. Chain EB, Mansford KRL, Opie LH. Effect of insulin on the pattern of glucose metabolism in the perfused working and Langendorff heart of normal and insulin-deficient rats. Biochem J 1969; 115: 537-546.
16. Depre C, Rider MH, Hue L. Mechanism of control of heart glycolysis. Eur J Biochem 1998; 258: 277-290.
17. Miller TB, Jr. Cardiac performance of isolated perfused hearts from alloxan diabetic rats. Am J Physiol 1979; 236: H 808-H 812.
18. Aas V, Kase ET, Solberg R, Jensen J, Rustan AC. Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells. Diabetologia 2004; 47: 1452-1461.
19. Neely JR, Whitefield CF, Morgan HE. Regulation of glycogenosis in hearts: effects of pressure development, glucose and FFA. Am J Physiol 1970; 219: 1083-1088.
20. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
21. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 1974; 36: 413-459.
22. Rodrigues B, Cam MC, McNeil JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998; 180: 53-57.
23. Heyliger CE, Rodrigues B, McNeill JH. Effect of choline and methionine treatment on cardiac dysfunction of diabetic rats. Diabetes 1986; 35: 1152-1157.
24. Saddik M, Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 1994; 72: 1110-1119.
25. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004; 18: 1692-1700.
26. Katz AM, Messineo FC. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 1981; 48: 1-24.
27. Maki M, Luotolahti M, Nuutila P, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996; 93: 1638-1666.
28. Lopaschuk GD, Saddik M. The relative contribution of glucose and fatty acids to ATP production in heart reperfused following ischaemia. Mol Cell Biochem 1992; 116: 111-116.
29. Opie L. Effect of regional ischemia on metabolism of glucose and fatty acids: relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res 1976; 38 (Suppl. 1): 52-68.
30. Briede J, Stivrina M, Stoldere Dz, Vigante B, Duburs G. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus. Cell Biochem Funct 2006; (In press). DOI:10.1027/cbf.1372
31. Barry WH, Bridge JHB. Intracellular calcium homeostasis in cardiac myocytes. Circulation 1993; 87: 1806-1815.
32. +)-ATPase induces positive inotropy in intact mouse heart in vivo. Biochem Biophys Res Commun 2006; 349: 582-587.
33. Briede J, Heidemanis K, Dabina I, Duburs G. Effect of cerebrocrast on the function of human platelets and release of the arachidonic acid from plasma membrane. Cell Biochem Funct 2002; 20: 177-181.
34. 2+ channels. Science 2003; 302: 1416-1418.
35. 2+ channels in cardiac pacemaking. J Pharmacol Sci 2005; 99: 197-204.
36. Henning SL, Wambolt RB, Schonekess BO, Lopaschuk GD, Allard MF. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation 1996; 93: 1549-1555.
37. Allard MF, Henning SL, Wambolt RB, Granleese SR, English DR, Lopaschuk GD. Glycogen metabolism in the aerobic hypertrophied rat heart. Circulation 1997; 96: 676-682.
38. Morgan H, Cadenas E, Regen D, Park C. Regulation of glucose uptake in muscle: II. Rate limiting step and effects of insulin and anoxia in heart muscle from diabetic rats. J Biol Chem 1961; 236: 262-269.
39. Morgan HE, Parmeggiani A. Regulation of glycogenolysis in muscle. II. Control of glycogen Phosphorylase reaction in isolated perfused heart. J. Biol Chem 1964; 239: 2435-2439.
40. Kraegen EW, Sowden JA, Halstead MB, et al. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immuno-isolation studies of GLUT 1 and GLUT 4. Biochem J 1993; 295: 287-293.
41. Fischer Y, Thomas J, Sevilla L, et al. Insulin-induced recruitment of glucose transporter 4 (GLUT 4) and GLUT 1 in isolated rat cardiac myocytes. J Biol Chem 1997; 272: 7085-7092.
42. de Leiris J, Opie LH. Effect of substrates and of coronary artery ligation on mechanical performance and on release of lactate dehydrogenase and creatine Phosphokinase in isolated working rat hearts. Cardiovasc Res 1978; 12: 585-596.
43. Wilkinson JH, Robinson JM, Johanson KP. Factors affecting the release of haemoglobin and enzymes from human erythrocytes. Ann Clin Biochem 1975; 12: 58-65.
44. 2+ current in rat cardiac myocytes. Cardiovasc Res 1999; 42: 113-120.
45. Sundell J, Knuuti J. Insulin and myocardial blood flow. Cardiovasc Res 2003; 57: 312-319.
46. 2+]I- independent positive inotropic effects in failing human myocardium. Circulation 2005; 111: 2588-2595.
47. Zeng G, Nystrom FH, Ravichandran LV, et al. Role for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000; 101: 1539-1545.
48. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000; 101: 660-667.
49. Kashiwaya Y, King MT, Veech RL. Substrate signalling by insulima ketone bodies ratio mimics insulin action in heart. Am J Cardiol 1997; 80: 50A-64A.